68 evolution "https:" "https:" "https:" "CMU Portugal Program FCT" positions at University of Basel
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
driving the development of innovative therapies that address unmet medical needs. With over 70 research groups and 800 employees, the Department of Biomedicine is the largest department within
-
. The position is available from 1 February 2026. The initial contract will be for one year. For more information on research in the Hondele lab see: https://www.biozentrum.unibas.ch/research/research
-
driving the development of innovative therapies that address unmet medical needs. With over 70 research groups and 800 employees, the Department of Biomedicine is the largest department within
-
a Swiss-wide research consortium funded by the Swiss National Science Foundation (SNSF). AntiResist is transforming antibiotic discovery and development through in vitro modelling of in-patient
-
senior members in the lab, and at the same time to play an active role in shaping and creating inspiring research and working environment. In line with our and Uni Basel values (https://www.unibas.ch/en
-
the lab, and at the same time to play an active role in shaping and creating an inspiring research and working environment. In line with our and Uni Basel values (https://www.unibas.ch/en/Research/Values
-
environment. In line with our and Uni Basel values ( https://www.unibas.ch/en/Research/Values-Ethics/Diversity-and-Inclusion.html ), we are committed to sustain and promote an inclusive culture, ensure equal
-
cellular biology. The position is available from 1 February 2026. The initial contract will be for one year. For more information on research in the Hondele lab see: https://www.biozentrum.unibas.ch/research
-
candidates with an outstanding research record in deep learning, in particular in one or several of the following areas: modeling and architecture development, domain adaptation & continual learning, agentic
-
a Swiss-wide research consortium funded by the Swiss National Science Foundation (SNSF). AntiResist is transforming antibiotic discovery and development through in vitro modelling of in-patient